Epidemiology and Outcomes of Neurofibromatosis Type 1 (NF-1): Multicenter Tertiary Experience

References

• Petrák B, Bendová Š, Lisý J, et al. Nevrofibromatoza von Recklinghausen tip 1 (NF1) - klinična slika in molekularno-genetska diagnostika [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic]. Ceskoslovenska patologie. 2015;51(1):34–40. Slovenian.
   PubMedGoogle Scholar
• Kissil JL, Blakeley JO, Ferner RE, et al. What’s new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiers. Am J Med Genet A. 2010;152a(2):269–283. doi:10.1002/ajmg.a.33189
   PubMedGoogle Scholar
• Uusitalo E, Leppävirta J, Koffert A, et al. Incidence and mortality of neurofibromatosis: a total population study in Finland. J Invest Dermatol. 2015;135(3):904–906. doi:10.1038/jid.2014.465
   PubMed Web of Science ®Google Scholar
• Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics. 2009;123(1):124–133. doi:10.1542/peds.2007-3204
   PubMed Web of Science ®Google Scholar
• Jouhilahti EM, Peltonen S, Heape AM, Peltonen J. The pathoetiology of neurofibromatosis 1. Am J Pathol. 2011;178(5):1932–1939. doi:10.1016/j.ajpath.2010.12.056
   PubMed Web of Science ®Google Scholar
• Legius E, Marchuk DA, Collins FS, Glover TW. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nature Genet. 1993;3(2):122–126. doi:10.1038/ng0293-122
   PubMed Web of Science ®Google Scholar
• DeBella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000;105(3 Pt 1):608–614. doi:10.1542/peds.105.3.608
   PubMed Web of Science ®Google Scholar
• Valero MC, Martín Y, Hernández-Imaz E, et al. A highly sensitive genetic protocol to detect NF1 mutations. J Mol Diagn. 2011;13(2):113–122. doi:10.1016/j.jmoldx.2010.09.002
   PubMed Web of Science ®Google Scholar
• Legius E, Messiaen L, Wolkenstein P, et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. 2021;23(8):1506–1513. doi:10.1038/s41436-021-01170-5
   PubMed Web of Science ®Google Scholar
• Tadini G, Brems H, Legius E. Proposal of new diagnostic criteria. In: Tadini G, Legius E, Brems H, editors. Multidisciplinary Approach to Neurofibromatosis Type 1. Cham: Springer International Publishing; 2020:309–313.
   Google Scholar
• F JM. Neurofibromatosis 1. Seattle (WA): University of Washington; 1998.
   Google Scholar
• Shah KN. The diagnostic and clinical significance of café-au-lait macules. Pediatr Clin N Am. 2010;57(5):1131–1153. doi:10.1016/j.pcl.2010.07.002
   PubMed Web of Science ®Google Scholar
• Duong TA, Sbidian E, Valeyrie-Allanore L, et al. Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France. Orphanet J Rare Dis. 2011;6(1):1–8. doi:10.1186/1750-1172-6-18
   PubMedGoogle Scholar
• Rasmussen SA, Yang Q, Friedman JM. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet. 2001;68(5):1110–1118. doi:10.1086/320121
   PubMed Web of Science ®Google Scholar
• Barreto-Duarte B, Andrade-Gomes FH, Arriaga MB, Araújo-Pereira M, Cubillos-Angulo JM, Andrade BB. Association between neurofibromatosis type 1 and cerebrovascular diseases in children: a systematic review. PLoS One. 2021;16(1):1–12. doi:10.1371/journal.pone.0241096
   Web of Science ®Google Scholar
• Oderich GS, Sullivan TM, Bower TC, et al. Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results. J Vascular Surg. 2007;46(3):475–484. doi:10.1016/j.jvs.2007.03.055
   PubMed Web of Science ®Google Scholar
• Terry AR, Jordan JT, Schwamm L, Plotkin SR. Increased risk of cerebrovascular disease among patients with neurofibromatosis type 1: population-based approach. Stroke. 2016;47(1):60–65. doi:10.1161/STROKEAHA.115.011406
   PubMed Web of Science ®Google Scholar
• Bernardo P, Cinalli G, Santoro C. Epilepsy in NF1: a systematic review of the literature. Child’s Nerv Syst. 2020;36(10):2333–2350. doi:10.1007/s00381-020-04710-7
   PubMed Web of Science ®Google Scholar
• Bashiri FA, AlZamil LR, Aldhuwayhi RA. Clinical spectrum of neurofibromatosis type 1 among children in a tertiary care center. Neurosciences. 2020;25(5):375–379. doi:10.17712/nsj.2020.5.20200081
   PubMed Web of Science ®Google Scholar
• Tucker T, Schnabel C, Hartmann M, et al. Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1). J Med Genet. 2009;46(4):259–265. doi:10.1136/jmg.2008.061895
   PubMed Web of Science ®Google Scholar
• Bizzarri C, Bottaro G. Endocrine implications of neurofibromatosis 1 in childhood. Hormone Res Paediatrics. 2015;83(4):232–241. doi:10.1159/000369802
   PubMed Web of Science ®Google Scholar
• Alfurayh MA, Alawad NK, Bin Akrish AM, et al. Phenotype and Genotype of Saudi Pediatric Patients With Neurofibromatosis Type 1: a Seven-Year Multicenter Experience From Saudi Arabia. Cureus. 2023;15:4.
   Web of Science ®Google Scholar
• Tabata MM, Li S, Knight P, Bakker A, Sarin KY. Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry. JCI Insight. 2020;5(16). doi:10.1172/jci.insight.136262
   PubMed Web of Science ®Google Scholar
• Aboutkidshealth. Neurofibromatosis type 1 (NF1); 2010. Available from: https://www.aboutkidshealth.ca/article?contentid=864&language=english. Accessed December 02, 2023.
   Google Scholar
• Wang MX, Dillman JR, Guccione J, et al. Neurofibromatosis from head to toe: what the radiologist needs to know. Radiographics. 2022;42(4):1123–1144. doi:10.1148/rg.210235
   PubMed Web of Science ®Google Scholar
• Helfferich J, Nijmeijer R, Brouwer OF, et al. Neurofibromatosis type 1 associated low grade gliomas: a comparison with sporadic low grade gliomas. Crit Rev Oncol/Hematol. 2016;104:30–41. doi:10.1016/j.critrevonc.2016.05.008
   PubMed Web of Science ®Google Scholar
• Russo C, Russo C, Cascone D, et al. Non-oncological neuroradiological manifestations in NF1 and their clinical implications. Cancers. 2021;13(8):1–20. doi:10.3390/cancers13081831
   Web of Science ®Google Scholar
• Tedesco MA, Di Salvo G, Natale F, et al. The heart in neurofibromatosis type 1: an echocardiographic study. Am Heart J. 2002;143(5):883–888. doi:10.1067/mhj.2002.122121
   PubMed Web of Science ®Google Scholar
• Lama G, Graziano L, Calabrese E, et al. Blood pressure and cardiovascular involvement in children with neurofibromatosis type1. Pediatr Nephrol. 2004;19(4):413–418. doi:10.1007/s00467-003-1397-5
   PubMed Web of Science ®Google Scholar
• Lin AE, Birch PH, Korf BR, et al. Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. Am J Med Genet. 2000;95(2):108–117. doi:10.1002/1096-8628(20001113)95:2<108::AID-AJMG4>3.0.CO;2-0
   PubMed Web of Science ®Google Scholar
• Toro G, Santoro C, Ambrosio D, et al. Natural history of scoliosis in children with NF1: an observation study. Healthcare. 2021;9(7):1–10. doi:10.3390/healthcare9070881
   Web of Science ®Google Scholar
• Sorrentino U, Bellonzi S, Mozzato C, et al. Epilepsy in NF1: epidemiologic, genetic, and clinical features. A monocentric retrospective study in a cohort of 784 patients. Cancers. 2021;13(24):1–14. doi:10.3390/cancers13246336
   Web of Science ®Google Scholar
• Soucy EA, van Oppen D, Nejedly NL, Gao F, Gutmann DH, Hollander AS. Height assessments in children with neurofibromatosis type 1. J Child Neurol. 2013;28(3):303–307. doi:10.1177/0883073812446310
   PubMed Web of Science ®Google Scholar
• Zhang W, Rhodes SD, Zhao L, et al. Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. Bone. 2011;48(6):1378–1387. doi:10.1016/j.bone.2011.03.760
   PubMed Web of Science ®Google Scholar
• Wang W, Nyman JS, Ono K, Stevenson DA, Yang X, Elefteriou F. Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I. Human Molecular Genetics. 2011;20(20):3910–3924. doi:10.1093/hmg/ddr310
   PubMed Web of Science ®Google Scholar
• Tanrıkulu B, Özek MM. Neurofibromatosis and Hydrocephalus. In: Cinalli G, Özek MM, Sainte-Rose C, editors. Pediatric Hydrocephalus. Cham: Springer International Publishing; 2019:1107–1118.
   Google Scholar
• Hospital for Special Surgery. Orthopedic complications of neurofibromatosis type 1: scoliosis, tibial dysplasia and other issues; 2021.
   Google Scholar
• Vogel AC, Gutmann DH, Morris SM. Neurodevelopmental disorders in children with neurofibromatosis type 1. Dev Med Child Neurol. 2017;59(11):1112–1116. doi:10.1111/dmcn.13526
   PubMed Web of Science ®Google Scholar
• Miguel CS, Chaim-Avancini TM, Silva MA, Louzã MR. Neurofibromatosis type 1 and attention deficit hyperactivity disorder: a case study and literature review. Neuropsychiatr Dis Treat. 2015;11:815–821. doi:10.2147/NDT.S75038
   PubMed Web of Science ®Google Scholar